Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Heat shock protein 70 (Hsp70) is a highly conserved family of molecular chaperone proteins found in virtually all living organisms. It plays a crucial role in cellular protection against various forms of physiological stress by assisting in the proper folding of nascent and stress-accumulated misfolded proteins, preventing aggregation, and facilitating the refolding or degradation of damaged proteins. Hsp70 also inhibits both caspase-dependent and caspase-independent apoptosis, thereby promoting cell survival under adverse conditions[1][2][3]. In addition to its intracellular functions, membrane-bound and extracellular forms have been identified with potential roles as therapeutic targets in cancer and neurodegenerative diseases[2]. Recombinant or exogenous Hsp70 has demonstrated tissue-protective effects in models of ischemic injury, neurodegeneration, inflammation, and cardiovascular disease[6]. Pharmacological induction or administration of recombinant Hsp70 is being explored for its neuroprotective properties as well as immunomodulatory effects relevant to oncology (e.g., cancer vaccines)[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on heat shock protein 70.